KMT2D and neoplasm: Taken together, these results demonstrate that GSDMD-mediated pyroptosis promotes tumor immunity and can sensitize refractory tumors to cytotoxic killing by tumor-infiltrated T lymphocytes, which at least partly account for the drastic suppression of Mll4−/− tumor progression in immune-competent mice treated with or without anti-PD-1 immunotherapy.